These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1827001)

  • 1. Prevention of stroke and brain damage with calcium antagonists in animals.
    Sauter A; Rudin M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):121S-127S. PubMed ID: 1827001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists for reduction of brain damage in stroke.
    Sauter A; Rudin M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S43-7. PubMed ID: 1695302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies with isradipine in stroke.
    Sauter A; Rudin M
    Drugs; 1990; 40 Suppl 2():44-51. PubMed ID: 2150641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals.
    Sauter A; Rudin M
    Am J Med; 1989 Apr; 86(4A):130-3. PubMed ID: 2523648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals.
    Sauter A; Rudin M; Wiederhold KH; Hof RP
    Am J Med; 1989 Apr; 86(4A):134-46. PubMed ID: 2523649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and hemodynamic effects of calcium channel blockade with isradipine after acute exercise.
    Cléroux J; Yardley C; Marshall A; Coulombe D; Lacourcière Y
    Am J Hypertens; 1992 Feb; 5(2):84-7. PubMed ID: 1532316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia.
    Chandra S; White RF; Everding D; Feuerstein GZ; Coatney RW; Sarkar SK; Barone FC
    Pharmacology; 1999 Jun; 58(6):292-9. PubMed ID: 10325574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of antihypertensive treatment with isradipine on the consequences of cerebral ischaemia in the spontaneously hypertensive rat.
    Bentahila S; Atkinson J; Capdeville C
    J Hypertens; 1991 Feb; 9(2):121-9. PubMed ID: 1849526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine.
    Lenhard SC; Strittmatter R; Price WJ; Chandra S; White RF; Barone FC
    Pharmacology; 2008; 81(1):1-10. PubMed ID: 17726342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MPC-1304, a novel calcium antagonist, on stroke-prone spontaneously hypertensive rats.
    Niwa M; Shigematsu K; Maeda T; Fujimoto M; Yamashita K; Kataoka Y; Taniyama K
    Arch Int Pharmacodyn Ther; 1994; 327(3):309-29. PubMed ID: 7848014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of treatment with Ca(2+) antagonists on cerebral vasculature of spontaneously hypertensive rats.
    Sabbatini M; Tomassoni D; Amenta F
    Mech Ageing Dev; 2001 Jun; 122(8):795-809. PubMed ID: 11337009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
    Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
    Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
    Lüscher TF; Waeber B
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S1-3. PubMed ID: 1720476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
    Edouard A; Dartayet B; Ruegg C; Samii K
    Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isradipine in hypertension.
    Hansson L
    Drugs; 1990; 40 Suppl 2():10-4. PubMed ID: 2150633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.